FC
EW icon

Fulcrum Capital’s Edwards Lifesciences EW Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$10.3M Buy
131,109
+4,842
+4% +$379K 2.17% 16
2025
Q1
$9.15M Buy
126,267
+4,255
+3% +$308K 2.03% 17
2024
Q4
$9.03M Buy
122,012
+4,107
+3% +$304K 1.89% 17
2024
Q3
$7.78M Buy
117,905
+4,067
+4% +$268K 1.69% 23
2024
Q2
$10.5M Buy
113,838
+267
+0.2% +$24.7K 2.39% 11
2024
Q1
$10.9M Buy
113,571
+479
+0.4% +$45.8K 2.58% 11
2023
Q4
$8.62M Buy
113,092
+19,096
+20% +$1.46M 2.23% 15
2023
Q3
$6.51M Buy
93,996
+322
+0.3% +$22.3K 1.89% 18
2023
Q2
$8.84M Sell
93,674
-3,069
-3% -$289K 2.32% 12
2023
Q1
$8M Buy
96,743
+7,034
+8% +$582K 2.15% 14
2022
Q4
$6.69M Buy
89,709
+6,439
+8% +$480K 1.93% 19
2022
Q3
$6.88M Sell
83,270
-2,487
-3% -$206K 2.04% 19
2022
Q2
$8.16M Sell
85,757
-1,212
-1% -$115K 2.56% 13
2022
Q1
$10.2M Buy
86,969
+774
+0.9% +$91.1K 2.74% 11
2021
Q4
$11.2M Buy
86,195
+1,039
+1% +$135K 2.42% 13
2021
Q3
$9.64M Buy
85,156
+106
+0.1% +$12K 2.31% 11
2021
Q2
$8.81M Buy
85,050
+2,300
+3% +$238K 2.21% 17
2021
Q1
$6.92M Buy
82,750
+3,454
+4% +$289K 1.98% 22
2020
Q4
$7.23M Buy
79,296
+3,749
+5% +$342K 2.16% 18
2020
Q3
$6.03M Sell
75,547
-6,776
-8% -$541K 2.18% 25
2020
Q2
$5.69M Buy
82,323
+53,395
+185% +$3.69M 2.16% 26
2020
Q1
$5.46M Buy
28,928
+110
+0.4% +$20.7K 2.48% 23
2019
Q4
$6.72M Buy
28,818
+74
+0.3% +$17.3K 2.08% 20
2019
Q3
$6.32M Sell
28,744
-27
-0.1% -$5.94K 2.16% 17
2019
Q2
$5.32M Buy
28,771
+6,262
+28% +$1.16M 1.95% 26
2019
Q1
$4.31M Buy
22,509
+665
+3% +$127K 1.63% 31
2018
Q4
$3.35M Buy
21,844
+1,310
+6% +$201K 1.51% 32
2018
Q3
$3.58M Buy
20,534
+476
+2% +$82.9K 1.39% 31
2018
Q2
$2.92M Buy
+20,058
New +$2.92M 1.39% 28